Related by context. Frequent words. (Click for all words.) 61 +#-#-# [018] 60 mailto @ 60 +#- 0 [002] 59 http:/www.presseportal.de Contact 59 +#-#-#-# [018] 58 @ fd.com 56 +#-#-#-# +#-#-#-# 56 officieel geldend 56 Phone +1 55 Investor Relations Contacts 55 +# 0 #-#-# [003] 55 Investor Relations Tel 55 +#-#-# [007] 54 +#-#-# [003] 54 @ edelman.com 54 Tel #.#.# 54 Media Inquiries 54 Disclaimer Deze bekendmaking 54 +#-#-#-# [015] 54 Phone +# 0 53 Telephone +# 0 53 Media Enquiries 53 Oncolytics please 53 die Verivox GmbH sondern 53 folgenden Meldung ist nicht 53 Im Internet recherchierbar 53 @ mailto 53 +#-#-#-# [012] 53 Phone +#-#-#-# [004] 52 verantwortlich 52 MEDIA CONTACT 52 CONTACTS 52 Editorial Contacts 52 der Autor 52 Phone +#-#-#-# Email [003] 52 PLEASE CONTACT 52 +#-#-#-# [014] 52 Tel +#-#-#-# Email [006] 52 Tel +#-#-#-# [007] 52 http:/profnet.prnewswire.com/Subscriber/ExpertProJim Argue 51 Tel +# [001] 51 Fax #.#.# 51 MEDIA CONTACTS 51 +#-#-# [028] 51 Tel +1 51 Gallery Available http:/www.businesswire.com/cgi-NSSE 51 +#-#-#-# ext [001] 51 Photo Desk photodesk@prnewswire.com 51 Investor Relations Contact 51 Fax +1 51 Email Contact 51 information visit www.abiresearch.com 51 Copyright Business Wire 51 Tel +# 0 51 HIGH GAMES 51 CONTACT Investor Relations 50 EVC Group 50 Investor Contacts 50 #-# ext.# [001] 50 +# 0 [002] 50 #-#-# ext.# [003] 50 Investor Relations Tel +#-#-#-# [002] 50 +1 #-#-# 50 For moreinformation 50 HealthDay Reporter 49 +#-#-# [017] 49 Media Contacts 49 call +#.#.#.# 49 Phone #.#.# 49 href = mailto 49 +#-#-#-# @ [005] 49 Fax +# [002] 49 WITHOUT FOOTBALL ASSOCIATION PREMIER 49 INVESTOR RELATIONS 49 PondelWilkinson Inc. 49 investor.relations @ 49 +1- 49 fax +# 0 49 Phone +# [002] 49 UNION TRIBUNE STAFF WRITER 49 Photos Multimedia 49 #.#.# x# [003] 48 http:/www.presseportal.de Further inquiry 48 HYPERLINK mailto 48 Stephanie Carrington 48 +#-#-#-# [004] 48 #.#.# Email 48 FOR FURTHER INFORMATION 48 @ comcast.net 48 +# [003] 48 +1 #.#.# 48 Originaltext 48 mailto 48 Contacts Investor Relations 48 THIS RELEASE 48 ots Originaltext 47 +# # [007] 47 Contact 47 FOR FURTHER INFORMATION CONTACT 47 #-#-#/# [002] 47 @ dowjones.com